Valuation: Virbac

Market Cap 2.89B 3.29B 2.7B 2.48B 4.64B 316B 4.76B 32.04B 12.53B 156B 12.37B 12.1B 540B P/E 2026 *
17x
P/E 2027 * 15.3x
Enterprise Value 3.02B 3.44B 2.82B 2.59B 4.84B 329B 4.96B 33.44B 13.08B 163B 12.91B 12.63B 563B EV / Sales 2026 *
1.95x
EV / Sales 2027 * 1.8x
Free-Float
49.03%
Yield 2026 *
0.5%
Yield 2027 * 0.59%
1 day+0.58%
1 week+1.61%
Current month+4.51%
1 month+1.61%
3 months-5.05%
6 months-4.79%
Current year-2.80%
1 week 331
Extreme 331
347.5
1 month 312.5
Extreme 312.5
350
Current year 312.5
Extreme 312.5
389.5
1 year 296
Extreme 296
389.5
3 years 239
Extreme 239
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 2025-08-31
Chief Executive Officer 50 2024-09-26
Chief Operating Officer 64 2021-12-31
Director TitleAgeSince
Chairman 61 2006-03-31
Director/Board Member 68 2010-07-27
Director/Board Member 65 2017-09-04
Date Insider Type Main position Quantity % Market Cap.
4/22/24 Sell

Chief Executive Officer

1,688 0.0200%
4/22/24 Sell

Chief Executive Officer

810 0.0096%
4/22/24 Sell

Chief Executive Officer

140 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
+0.58%+1.61%-4.53%+19.21% 3.3B
+0.54%+5.04%-48.39%-58.57% 32.49B
+3.41%+4.14%+83.39%+118.64% 12.75B
+1.34%+4.27%-17.15%+1.34% 3.73B
-0.85%+3.11%-4.03%+29.37% 1.92B
+3.68%+0.35%+29.19%+14.13% 1.8B
+1.59%+9.29%+31.92%+155.18% 1.47B
+1.65%-1.42%-26.43%-15.45% 1.05B
+0.31%0.00%-18.63%-47.72% 966M
+0.27%+1.67%-7.59%-22.17% 964M
Average +1.38%+1.53%+1.77%+19.40% 6.04B
Weighted average by Cap. +1.83%+1.93%-9.10%-1.59%

Financials

2026 *2027 *
Net sales 1.55B 1.76B 1.45B 1.33B 2.49B 169B 2.55B 17.15B 6.71B 83.6B 6.62B 6.48B 289B 1.65B 1.87B 1.54B 1.41B 2.64B 179B 2.71B 18.22B 7.13B 88.81B 7.04B 6.88B 307B
Net income 171M 195M 160M 147M 274M 18.65B 281M 1.89B 741M 9.23B 731M 715M 31.91B 190M 216M 177M 163M 305M 20.71B 312M 2.1B 822M 10.25B 812M 794M 35.42B
Net Debt 127M 144M 118M 109M 203M 13.82B 208M 1.4B 549M 6.84B 542M 530M 23.63B 75.16M 85.53M 70.16M 64.38M 121M 8.19B 123M 832M 325M 4.05B 321M 314M 14.02B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
26-07-29 347.50 +0.58% 3,847
26-07-28 €345.50 +2.52% 4,343
26-07-27 €337.00 +1.51% 3,790
26-07-24 €332.00 -0.75% 5,181
26-07-23 €334.50 -4.43% 5,064
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
345.50EUR
Average target price
412.00EUR
Spread / Average Target
+19.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock